Label: PERDIEM- sennosides, stimulant laxative tablet

  • NDC Code(s): 0067-8143-01
  • Packager: Haleon US Holdings LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 7, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Sennosides 15 mg

  • Purpose

    Stimulant Laxative

  • Uses

    ● relieves occasional constipation (irregularity)

    ● generally produces bowel movement in 6 to 12 hours

  • Warnings

    Do not use laxative product when abdominal pain, nausea or vomiting are present unless directed by a doctor

    Ask a doctor or pharmacist before use if you

    ● have noticed a sudden change in bowel habits that persists over a period of 2 weeks

    ● are taking any other drug. Take this product 2 or more hours before or after other drugs. Laxatives may affect how other drugs work.

    When using this product

    ● do not use for a period longer than 1 week

    Stop use and ask a doctor if

    ● rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    ● swallow tablet with a glass of water

    ● swallow tablet whole, do not crush, break or chew

    Adults and children 12 years of age and older

    2 tablets once or twice daily

    Children 6 to under 12 years of age

    1 tablet once or twice daily

    Children under 6 years of age

    ask a doctor
  • Other Information

    ● each tablet contains:calcium 45mg, magnesium 5 mg

    ● store at controlled room temperature 20-25°C (68-77°F).

  • Inactive Ingredients

    acacia, calcium carbonate, carnuba wax, corn starch, dibasic calcium phosphate, iron oxide black, iron oxide red, iron oxide yellow, magnesium stearate, methylparaben, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, propylene glycol, propylparaben, shellac, silicon dioxide, sodium benzoate, sodium lauryl sulfate, sucrose, talc, titanium dioxide

  • Questions?

    call 1-855-297-3036

  • Package/Label Principal Display Panel

    12958_Perdiem_60ct.jpg
  • Primary Label

    12957_Perdiem bottle 60 ct.jpg
  • Primary Label

    12957_Perdiem bottle 60 ct.jpg
  • Primary Label

    12957_Perdiem 60ct_pdp.jpg
  • INGREDIENTS AND APPEARANCE
    PERDIEM 
    sennosides, stimulant laxative tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0067-8143
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES15 mg
    Inactive Ingredients
    Ingredient NameStrength
    ACACIA (UNII: 5C5403N26O)  
    CALCIUM CARBONATE (UNII: H0G9379FGK)  
    CARNAUBA WAX (UNII: R12CBM0EIZ)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)  
    POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    SHELLAC (UNII: 46N107B71O)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    SUCROSE (UNII: C151H8M554)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    Colorbrown (Tan) Scoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code Perdiem
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0067-8143-011 in 1 CARTON07/01/2017
    160 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00707/01/2017
    Labeler - Haleon US Holdings LLC (079944263)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!